Related Articles
Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line
Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
Integrin β1‑mediated acquired gefitinib resistance in non‑small cell lung cancer cells occurs via the phosphoinositide 3-kinase‑dependent pathway
Effect of Vinorelbine on cell growth and apoptosis induction in human osteosarcoma in vitro